Shopping Cart - CHF 0.00

You have no items in your shopping cart.

Return to Previous Page

Availability: In stock

Myristoyl-(Lys¹²·²⁷·²⁸)-VIP-Gly-Gly-Thr (free acid) trifluoroacetate salt
Myristoyl-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Lys-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Lys-Lys-Gly-Gly-Thr-OH trifluoroacetate salt


Product No. Pack Size Available ADS InfoAnalytical Data Sheet List Price Online Order Price Qty
4037992.0500 0.5 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 265.00
CHF 246.45 (7%)
4037992.1000 1 mg Ships within 3-5 business days  
CHF 459.00
CHF 426.87 (7%)


PG 99-465 is a high affinity, selective VPAC2 receptor antagonist. It exhibited a 100-fold preference for the VPAC2 over the VPAC1 receptor. The compound showed partial agonistic activity on the VPAC1 receptor and was inactive on the VPAC2 receptor transfected in CHO cells, as well as on naturally expressed human VPAC2 receptors in the SUP T1 cell line. Dickson et al. observed an agonistic effect of PG99-465 on the human VPAC1 and PAC1 receptors. When applied singly, PG99-465 increased [cAMP](i) at all three hVPAC/PAC receptor subtypes.
Catalog Number H-7292
Synonyms PG 99-465
Molecular Formula C₁₇₁H₂₈₃N₄₅O₄₇S
Relative Molecular Mass 3753.47
CAS Registry Number 2243219-86-3
Source Synthetic
Storage Conditions -20 ± 5 °C
Application Cancer Research